For Baxter International's peritoneal dialysis systems, should we prioritize miniaturization for patient mobility or larger capacity for extended use?

Introduction

The trade-off we're examining today is whether to prioritize miniaturization for patient mobility or larger capacity for extended use in Baxter International's peritoneal dialysis systems. This decision is crucial as it directly impacts patient quality of life, treatment efficacy, and Baxter's market position in the medical device industry. I'll analyze this trade-off by considering user needs, technical feasibility, business implications, and potential long-term impacts.

Step 1

Clarifying Questions (3 minutes)

• Based on recent market trends, I'm thinking patient mobility might be a key differentiator. Could you share any insights on how our competitors are positioning their peritoneal dialysis systems?

Why it matters: Helps understand our competitive landscape and potential market gaps. Expected answer: Competitors are focusing on home-based solutions but haven't fully addressed mobility. Impact on approach: Would influence whether we prioritize miniaturization as a unique selling point.

• Considering our user base, I'm assuming we have a mix of patients with different lifestyles and needs. Do we have data on the percentage of patients who prioritize mobility versus those who prefer longer periods between dialysis sessions?

Why it matters: Allows us to tailor our solution to the most significant user segment. Expected answer: 60% prioritize mobility, 40% prefer extended use. Impact on approach: Would help balance feature prioritization based on user preferences.

• From a technical standpoint, I'm curious about the current limitations in miniaturization. What's the smallest size we can achieve without compromising the system's effectiveness?

Why it matters: Determines the feasibility of our miniaturization efforts. Expected answer: Current technology allows for a 20% size reduction without performance loss. Impact on approach: Would set realistic goals for the miniaturization option.

• Regarding our business model, I'm wondering how this decision might impact our revenue streams. Are there any differences in pricing or profit margins between smaller, more mobile systems and larger capacity ones?

Why it matters: Ensures alignment with financial objectives. Expected answer: Smaller systems have higher margins but lower overall revenue per unit. Impact on approach: Would influence the balance between short-term profitability and long-term market share.

• Considering project timelines, how urgent is this decision? Are there any upcoming regulatory changes or market events that could impact our choice?

Why it matters: Helps prioritize this decision against other initiatives. Expected answer: FDA is reviewing guidelines for home dialysis devices in the next 18 months. Impact on approach: Would affect the timeline for development and potential phased approach.